Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.
Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.
Ionizing radiation (IR) plays a central role in the biomedical field, both for diagnosis and for the treatment of pathologies such as cancer. However, exposure to IR can cause significant cellular damage, affecting both tumor cells and neighbouring healthy tissue. In this context, the use of effective radioprotective agents is a necessity. Chitosan (CS), a natural biopolymer derived from chitin, stands out for its antioxidant, anti-inflammatory and reparative properties, as well as its biocompatibility and biodegradability. These characteristics make it a promising candidate for radiation protection. This chapter examines the radioprotective mechanisms of chitosan, in particular its ability to trap reactive oxygen species and enhance the activity of antioxidant enzymes. It also highlights its many biomedical applications, particularly in tissue engineering and controlled drug release. Finally, the limits to its clinical use and recent advances aimed at improving its physico-chemical properties are discussed, paving the way for new therapeutic strategies in radiation protection.
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
Scorpion venom is known for its richness in bioactive molecules, particularly peptides, which confer a wide range of remarkable biological activities. Notably, it exhibits antimicrobial, antitumor, and immunomodulatory effects. However, its clinical translation remains limited due to its poor stability, dose-dependent toxicity, and potential immunogenicity. In this context, biodegradable biomaterials have emerged as promising platforms to overcome these limitations. They enable precise, targeted, and sustained delivery of scorpion venom peptides. This chapter highlights an innovative approach based on the integration of scorpion venom into biodegradable biopolymer matrices for applications in modern medicine. By leveraging the unique properties of biodegradable biomaterials, this work outlines a roadmap for the development of next-generation clinical applications.